We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis
Status: Archived
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
Updated: 1/1/1970
Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
A Study of Bevacizumab to Prevent Malignant Ascites
Updated: 1/1/1970
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
A Study of Bevacizumab to Prevent Malignant Ascites
Updated: 1/1/1970
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
A Study of Bevacizumab to Prevent Malignant Ascites
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
A Study of Bevacizumab to Prevent Malignant Ascites
Updated: 1/1/1970
A Prospective, Phase II Trial of Intravenous Bevacizumab (Avastin) for the Prevention of Recurrent Malignant Ascites
Status: Archived
Updated: 1/1/1970
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Updated: 1/1/1970
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Updated: 1/1/1970
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Updated: 1/1/1970
Phase 1b Multiple Ascending Dose Study of BMS-833923 (XL139) Administered in Combination With Cisplatin and Capecitabine as First-Line Therapy in Patients With Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Status: Archived
Updated: 1/1/1970
Enhancing Detection of Small Esophageal Varices by PillCam ESO
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
Enhancing Detection of Small Esophageal Varices by PillCam ESO
Updated: 1/1/1970
A New Technique to Enhance Detection of Small Esophageal Varices by PillCam ESO Capsule Endoscopy
Status: Archived
Updated: 1/1/1970
Effect of Vitamin D3 on Vascular Function
The Effect of Cholecalciferol (Vitamin D3) on Vascular Function and Cardiovascular Risk Factors
Status: Archived
Effect of Vitamin D3 on Vascular Function
Updated: 1/1/1970
The Effect of Cholecalciferol (Vitamin D3) on Vascular Function and Cardiovascular Risk Factors
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Updated: 1/1/1970
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
Status: Archived
Updated: 1/1/1970